Revance(US:RVNC) Prnewswire·2025-02-06 10:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and material breaches related to a Distribution Agreement with Teoxane [1][2]. Summary by Sections Allegations - The complaint alleges that Revance was in material breach of the Distribution Agreement with Teoxane, which granted Revance exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [1]. - The breach subjected the company to increased risks of litigation, monetary losses, and reputational harm [1]. - These issues raised the risk of delays or amendments to a tender offer, making the company's public statements materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from February 29, 2024, to December 6, 2024 [1]. - Shareholders are encouraged to register for the class action by March 4, 2025, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].